Personal Information
Unternehmen/Arbeitsplatz
Moscow, Russian Federation Russian Federation
Beruf
Partner at Kesarev Consulting
Branche
Consulting / Advisory
Webseite
www.kesarev.com
Info
Listen to my new song https://youtu.be/x6_g6mzk2yU
17+ years of professional in house and consulting experience in public affairs, public relations and crisis communications.Successfully developed and handled complex reputational management and advocacy campaigns aimed at 1) improving business climate, 2) influencing policies on particular issues, 3) and boosting clients' publicity. Highlights of qualification: GR and Policy - Leadership and management of Public Affairs projects in Russia and CIS: advocacy, trust building, corporate responsibility and social projects, community relations and external affairs, high profile campaigns, executive visits, etc.
Tags
russia
grayling
wto
ВТО
eu
pericles
sanctions
коммуникации
pr
fdi
consequences
us
gr
Россия
doing business
public affairs
japan
switzerland
uk
export administration regulations
norway
canada
australia
contracts
dual use technologies
ofac directive 4
european export controls
types of sanctions; us; russia; ssi lists
compliance and damage control
types of sanctions; us; russia
social development
economics
human capital
fiscal policy
социальное развитие
бюджетная политика. russia
человеческий капитал
экономика
regions
регионы
types of sanctions; percentage of sanctions per co
АКОС
pr navigator
связи с госорганами
связи с общественностью
selection of a consultant
выбор консультанта
tender process
тендерный процесс
key trends of pr market in 2013
ключевые тенденции рынка pr
ключевые события
key developments
us-russia relations
international relations
regulatory trends
the moscow times
corruption
federal and regional officials
localization
governement
brownfield
consulting
greenfield
ведение бизнеса
business
бизнес
research
исследование
тенденции в pr
pr сообщество
изменения в потреблении
тренды в pr
потребитель
foreign direct investment
customs union
government relations
putin
mega government
perception research
accession consequences
strategy 2020
russian
pharma
Mehr anzeigen